Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Retina Synthesis
Claim This Podcastby Retina Synthesis
Podcast Overview
Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.
Language
🇺🇲
Publishing Since
2/26/2021
Reach the team behind Retina Synthesis
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

June 8, 2026
Home OCT in Management of Neovascular AMD
In this episode, we discuss the latest developments in the use of artificial intelligence in home OCT for management of neovascular AMD with Professor Anat Loewenstein of Tel Aviv Medical Center and President, Israeli Ophthalmology Society.

June 4, 2026
Faricimab in the Treatment of DME: Long Term 'Results
We discuss long term results of faricimab treatment of DME, with the first author of the Ophthalmology article on the results of Rhone-X trial, Dr. Veeral Sheth, Director of Clinical Research at University Retina in Chicago.

May 28, 2026
Xelafaslatide for the Treatment of Geographic Atrophy
In our latest episode we discuss the results of a novel approach to the treatment of geographic atrophy using Xelafaslatide a Fas inhibitor with Dr. David Zacks, Professor of Ophthalmology at the Kellogg Eye Center at the University of Michigan.
180 total episodes available
Similar Podcasts
Discover related shows you might enjoy

New Retina Radio by Eyetube
Retina Today

ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
American Society of Retina Specialists (ASRS)

RETINA Journal Podcasts
Jonathan L. Prenner, MD

Talking Euretina
Whipsmart Media

MedEdTalks - Ophthalmology
Vindico Medical Education

Ophthalmology Journal
American Academy of Ophthalmology

Headlight in the fog: The Uveitis Podcast
Drs. Akshay Thomas & Laura Kopplin.

RetinUp Podcast
RetinUp Podcast, LLC

Experts InSight
American Academy of Ophthalmology

JAMA Ophthalmology Author Interviews
JAMA Network

Pupil Pod
Eyetube

Invest Like the Best with Patrick O'Shaughnessy
Colossus | Investing & Business Podcasts

The Rest Is Politics: US
Goalhanger

All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC

Mayo Clinic Ophthalmology Podcast
MayoClinicOphthalmology
Deep-dive analytics for Retina Synthesis
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Retina Synthesis?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
